Skip to main content
. 2014 Apr 15;9(8):845–850. doi: 10.4103/1673-5374.131601

Table 2.

BrdU-positive cells (percentage) derived from bone marrow mesenchymal stem cells after citalopram treatment versus control medium

graphic file with name NRR-9-845-g006.jpg